Skip to main content
Premium Trial:

Request an Annual Quote

Zeptosens Licenses Reagents from Cell Signaling Technology

NEW YORK, April 19 (GenomeWeb News) - Zeptosens of Witterswil, Switzerland announced today that it has signed an agreement with Beverly, Mass.-based Cell Signaling Technology for the use of CST's reagents in Zeptosens' ZeptoMARK protein array platform.

 

The reagents used will include phosphospecific antibodies to kinases and other signaling molecules, according to the companies.

 

Financial details of the agreement were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.